Drug Type Small molecule drug |
Synonyms LPH5 |
Target |
Mechanism 5-HT2A receptor agonists(Serotonin 2a (5-HT2a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H18F3NO2 |
InChIKeyNZKYTYHIERLZBG-SECBINFHSA-N |
CAS Registry2641630-97-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder, Treatment-Resistant | Preclinical | DK | 30 Jan 2022 | |
Depressive Disorder | Preclinical | DK | Beckley Psytech Ltd.Startup | - |